Literature DB >> 113423

Comparative effect of calcium and of the adrenergic system on calcitonin secretion in man.

N M Vora, G A Williams, G K Hargis, E N Bowser, W Kawahara, B L Jackson, W J Henderson, S C Kukreja.   

Abstract

This study evaluated the effects of adrenergic agents on immunoreactive calcitonin (iCT) secretion in normal man, and compared the time course and magnitude of these adrenergic effects with those caused by modifying calcium (Ca) ion concentration. Ca infusion (15 mg Ca++/kg iv in 4 h) significantly increased plasma iCT within 1 h, reaching 140 +/- 8% of baseline at 4 h. EDTA (50 mg/kg iv in 2 h) significantly decreased plasma iCT within 15 min, with nadir value of 53 +/- 4.9% of baseline at 2 h. The beta-adrenergic agonist, isoproterenol, significantly increased plasma iCT with 5 min, reaching 136 +/- 5.9% of baseline at 30 min. The alpha-adrenergic antagonist, phentolamine, significantly increased iCT within 15 min, reaching 132 +/- 8.6% of baseline at 45 min. The beta-adrenergic antagonist, propranolol, significantly suppressed iCT with 15 min, reaching 51.8 +/-6.3% of baseline at 2 h. Therefore, 1) the adrenergic system (without induced change in serum Ca) can modify CT secretion to as great a degree as can change in Ca ion concentration induced by standard Ca and EDTA infusion tests and 2) even basal secretion of CT can be modified by adrenergic influences. These data strongly suggest 1) that the adrenergic system is an effective modifier of CT secretion and 2) that the adrenergic system, as well as Ca ion concentration, may play an improtant physiological role in control of CT secretion in man.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 113423     DOI: 10.1210/jcem-46-4-567

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

1.  Adenylate cyclase of a human medullary thyroid carcinoma.

Authors:  S Matsukura; T Kakita; M Fukase; T Fujita
Journal:  Experientia       Date:  1981-05-15

Review 2.  Calcitonin: perspectives in current concepts.

Authors:  H J Wolfe
Journal:  J Endocrinol Invest       Date:  1982 Nov-Dec       Impact factor: 4.256

3.  Calcium homeostasis in the first days of life in relation to feeding.

Authors:  F Bagnoli; S Bruchi; S Sardelli; G Buonocore; L Vispi; F Franchi; R Bracci
Journal:  Eur J Pediatr       Date:  1985-05       Impact factor: 3.183

4.  Calcitonin and parathyroid hormone in newborn infants with fracture of the clavicle.

Authors:  F Bagnoli; S Bruchi; S Sardelli; L Vispi; G Buonocore; F Franchi; R Bracci
Journal:  Calcif Tissue Int       Date:  1984-07       Impact factor: 4.333

5.  Pre- and postoperative studies of plasma calcitonin in primary hyperparathyroidism.

Authors:  P W Lambert; H Heath; G W Sizemore
Journal:  J Clin Invest       Date:  1979-04       Impact factor: 14.808

6.  Lack of influence of isoproterenol, propranolol, and dopamine on immunoreactive parathyroid hormone and calcitonin in normal man.

Authors:  S Epstein; H Heath; N H Bell
Journal:  Calcif Tissue Int       Date:  1983       Impact factor: 4.333

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.